Expression of the Slc12a1 Gene in Pancreatic β-Cells: Molecular Characterization and in silico Analysis

Document Type


Publication Date



The solute carrier protein family 12 group A, member one (Slc12a1) and two (Slc12a2) encode several splice variants of the kidney-specific and the ubiquitous isoforms, respectively, of the bumetanide (BTD)-sensitive Na-dependent K2Cl co-transporter. The Slc12a2 co-transporter is involved in the maintenance of a high intracellular chloride concentration [Cl]i in β-cells and its inhibition with BTD blocks glucose-induced insulin secretion. In β-cells, [Cl]i plays an important role in glucose-induced depolarization and insulin secretion. Glucose promotes electrogenic efflux of Cl contributing to β-cell's electrical and secretory activity. To identify the expression pattern of Slc12a1 and Slc12a2 genes in β-cells we have used RT-PCR, Western blotting and immunolocalization studies in mouse pancreatic islets, β-cell lines and rat tissues. Our results demonstrate expression of specific splice variants of Slc12a1 and Slc12a2 transcripts in β-cells i.e., variants 1 of Slc12a1 (NKCC2A) and Slc12a2 (NKCC1a). Molecular cloning and characterization of Slc12a1 variant 1 transcripts from β-cells revealed an alternative splicing event involving the 5'-UTR region. NKCC2A expression at the protein level in islets and β-cells was confirmed by immunoblotting and immunolocalization. Further, NKCC2A, NKCC1a and pro-insulin co-localized in β-cells but not in the exocrine pancreas. Therefore, our results provide for the first time evidence of NKCC2A expression in pancreatic β-cells where it may play a role in insulin secretion.


In the original publication of this article, the name of Dr. Francisco J. Alvarez-Leefmans was omitted in the submitted manuscript. His name should be included as second author of the paper.

This correction to this article appears in Cellular Physiology and Biochemistry, 31(2-3), p. 486, 2013. DOI: 10.1159/000350063.



Find in your library

Off-Campus WSU Users